Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of Rocuronium

NCT05718934 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

144

Enrollment

OTHER

Sponsor class

Conditions

Neuromuscular Blockade

Interventions

DRUG: Neostigmine and glycopyrrolate
DRUG: Sugammadex

Sponsor

Ciusss de L'Est de l'Île de Montréal